Jill Clendening

Raymond Blind, PhD, left, Xin Tong, PhD, Rachana Haliyur, PhD, and Marcela Brissova, PhD, are part of a research team that discovered new information about the cellular dysfunction that occurs with a rare form of diabetes.

Study points to alternate therapy for rare form of diabetes

Vanderbilt University Medical Center researchers say an unexpected finding during the cellular analysis of human pancreatic tissue has revealed new information about a rare type of diabetes and underscores the importance of genetic testing for some individuals diagnosed with type 1 diabetes.

Event to celebrate VUMC employees set for March 7-8

Vanderbilt University Medical Center is hosting a special employee appreciation event — Celebrate the Difference WE Make Every Day! — to applaud recent successes and acknowledge the many contributions of the Medical Center’s employees during three sessions on March 7-8.

Vanderbilt surgery, engineering collaborators create new ‘home’

The Vanderbilt Institute for Surgery and Engineering (VISE) celebrated the opening of dedicated space in Medical Center North Dec. 12 with a technology showcase of more than two dozen collaborations advancing health care techniques from the lab to patient.

Policies for Action Research Hub at Vanderbilt created

Experts from Vanderbilt University School of Medicine’s Department of Health Policy and Vanderbilt University’s Peabody College of Education and Human Development are joining efforts to establish a Policies for Action (P4A) Research Hub at Vanderbilt to better understand and develop recommendations to address the needs of some of Tennessee’s most vulnerable children, including those in immigrant families and with prenatal exposure to opioids.

Early postpartum opioids linked with persistent usage

Vanderbilt researchers have published findings indicating that regardless of whether a woman delivers a child by cesarean section or by vaginal birth, if they fill prescriptions for opioid pain medications early in the postpartum period, they are at increased risk of developing persistent opioid use.

x-ray of stomach

Study defines association of oral anticoagulants and proton pump inhibitors to gastrointestinal bleeding risk

A Vanderbilt University Medical Center study published this week in JAMA shows that patients already at higher risk for gastrointestinal bleeding gain a marked protection from this risk when they take a proton pump inhibitor (PPI) in combination with an oral anticoagulant.

1 20 21 22 23 24 32